Century Therapeutics Inc

NASDAQ:IPSC  
24.74
-4.51 (-15.42%)
Earnings Announcements

Century Therapeutics Reports Q2 Loss Per Share Of $1.93

Published: 08/12/2021 12:34 GMT
Century Therapeutics Inc (IPSC) - Century Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates.
Century Therapeutics Inc Qtrly Loss per Share $1.93.
Century Therapeutics Inc - Cash, Cash Equivalents and Marketable Securities Were $440.0 Million As of June 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.41

More details on our Analysts Page.